Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
January 16, 2023EP 48: JPM Recap, no more mice trial requirements, generative ai proteins, GPCR, and more29 minutesPlayhttps://www.science.org/content/article/fda-no-longer-needs-require-animal-tests-human-drug-trialshttps://blogs.nvidia.com/blog/2023/01/12/generative-ai-proteins-evozyne/https://twitter.com/PDBeurope/status/1613121823452839936https://seekingalpha.com/news/3924363-structure-therapeutics-formerly-known-as-shoutti-files-for-100m-us-ipoSpecial thanks to Wuxi AppTec SynBioBeta, LatchBio, and Vial for their JPM events! ...moreShareView all episodesBy Nanome Inc.January 16, 2023EP 48: JPM Recap, no more mice trial requirements, generative ai proteins, GPCR, and more29 minutesPlayhttps://www.science.org/content/article/fda-no-longer-needs-require-animal-tests-human-drug-trialshttps://blogs.nvidia.com/blog/2023/01/12/generative-ai-proteins-evozyne/https://twitter.com/PDBeurope/status/1613121823452839936https://seekingalpha.com/news/3924363-structure-therapeutics-formerly-known-as-shoutti-files-for-100m-us-ipoSpecial thanks to Wuxi AppTec SynBioBeta, LatchBio, and Vial for their JPM events! ...more
https://www.science.org/content/article/fda-no-longer-needs-require-animal-tests-human-drug-trialshttps://blogs.nvidia.com/blog/2023/01/12/generative-ai-proteins-evozyne/https://twitter.com/PDBeurope/status/1613121823452839936https://seekingalpha.com/news/3924363-structure-therapeutics-formerly-known-as-shoutti-files-for-100m-us-ipoSpecial thanks to Wuxi AppTec SynBioBeta, LatchBio, and Vial for their JPM events!
January 16, 2023EP 48: JPM Recap, no more mice trial requirements, generative ai proteins, GPCR, and more29 minutesPlayhttps://www.science.org/content/article/fda-no-longer-needs-require-animal-tests-human-drug-trialshttps://blogs.nvidia.com/blog/2023/01/12/generative-ai-proteins-evozyne/https://twitter.com/PDBeurope/status/1613121823452839936https://seekingalpha.com/news/3924363-structure-therapeutics-formerly-known-as-shoutti-files-for-100m-us-ipoSpecial thanks to Wuxi AppTec SynBioBeta, LatchBio, and Vial for their JPM events! ...more
https://www.science.org/content/article/fda-no-longer-needs-require-animal-tests-human-drug-trialshttps://blogs.nvidia.com/blog/2023/01/12/generative-ai-proteins-evozyne/https://twitter.com/PDBeurope/status/1613121823452839936https://seekingalpha.com/news/3924363-structure-therapeutics-formerly-known-as-shoutti-files-for-100m-us-ipoSpecial thanks to Wuxi AppTec SynBioBeta, LatchBio, and Vial for their JPM events!